Hyperinsulinemia is a common symptom of T2DM, leading to decreased insulin signaling in the liver and skeletal muscle by increasing the p-s-IRS level, thereby resulting in insulin resistance (Ueno et al., 2005). This evidence concerns the gene INS and hyperinsulinism.